- Types of drug interaction
- Interactions with illegal and recreational drugs
- Testing drug levels
- Summary: Testing drug levels
- How are drugs absorbed?
- Variability in protease inhibitor levels
- Measuring protease inhibitor levels
- Cmin and antiviral activity
- Gender differences in drug levels
- Testing levels of other drugs
- The link with adherence
- Access to drug monitoring in the United Kingdom
- Key research on testing for drug levels
Testing drug levels
- Summary: Testing drug levels
- How are drugs absorbed?
- Variability in protease inhibitor levels
- Measuring protease inhibitor levels
- Cmin and antiviral activity
- Gender differences in drug levels
- Testing levels of other drugs
- The link with adherence
- Access to drug monitoring in the United Kingdom
- Key research on testing for drug levels
latest aidsmap news
- Higher LDL cholesterol levels mean better response to anti-HCV treatment in HIV/HCV coinfected patients
- Mother-to-child transmission in UK and Ireland has remained below 2% since 1998
- Texas jury concludes saliva of HIV-positive man a ‘deadly weapon’, sentenced to 35 yrs jail
- BHIVA: HIV-positive women at increased risk of late pregnancy loss
- BHIVA: Starting ART earlier has cost implications, public health benefits, says HPA
- Combining rifampicin with increased doses of lopinavir/ritonavir tablets leads to dangerous increases in liver enzymes
- Death rate in Malawi falls by up to 35% due to free HIV treatment
- HIV, but not HHV-8, found to increase risk of pulmonary arterial hypertension
- Circumcision and partner reduction should be priorities for HIV prevention, say US researchers
- Does tenofovir increase the risk of efavirenz-associated liver side-effects?